Chet R. Villa, MD
- Pediatric Cardiologist, Heart Failure & Transplantation
- Associate Professor, UC Department of Pediatrics
About
Biography
Children with severe heart disease once had few clinical options. While we’ve made many advances, it’s still critical that we improve therapeutic options and develop new approaches.
At Cincinnati Children’s, I care for children with complex medical needs and severe heart disease. This includes children with Duchenne muscular dystrophy, RASopathies, and those in need of ventricular assist device therapy and heart transplant.
My research is focused on finding ways to provide care to children and young adults with heart disease who have limited access to advanced therapies.
MD: University of Cincinnati College of Medicine, Cincinnati, OH, 2007.
Residency: Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH.
Certification: American Board of Pediatrics, 2010; Pediatric Cardiology, 2014.
Interests
Advanced heart failure; heart transplantation; cardiomyopathy; mechanical circulatory support
Services and Specialties
Cardiomyopathy, Rasopathy, Cardio-Oncology, Neuromuscular Cardiology, Neuromuscular Disorders
Interests
Ventricular assist device therapy; Duchenne muscular dystrophy
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation. 2023; 147:718-727.
Echocardiography Provides a Reliable Estimate of Total Cardiac Volume for Pediatric Heart Transplantation. Journal of the American Society of Echocardiography. 2023; 36:224-232.
Initial multicenter experience with ventricular assist devices in children and young adults with muscular dystrophy: An ACTION registry analysis. Journal of Heart Transplantation. 2023; 42:246-254.
Racial disparity exists in the utilization and post-transplant survival benefit of ventricular assist device support in children. Journal of Heart Transplantation. 2023.
Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction. Journal of Heart Transplantation. 2022; 41:1773-1780.
Abstract 11615: The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation. 2022; 146:a11615-a11615.
Ventricular Assist Device Outcomes in Infants and Children With Stage 1 Single Ventricle Palliation. ASAIO Journal. 2022; 68:e188-e195.
SynCardia Temporary Total Artificial Heart: Single-Center Experience at a Children's Hospital. ASAIO Journal. 2022; 68:1379-1382.
Comparing donor and recipient total cardiac volume predicts risk of short-term adverse outcomes following heart transplantation. Journal of Heart Transplantation. 2022; 41:1581-1589.
Decreased Risk of Strokes in Children with Ventricular Assist Devices Within ACTION. Pediatric Cardiology. 2022; 43:1379-1382.
From the Blog
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2022 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey